Press Release Covis Pharma Responds to Presiding Officer’s Report Summarizing FDA Advisory Committee Hearing – Company Has Requested an Orderly Wind-down in Effort to Voluntarily Withdraw Makena® Zug, Switzerland, March 07, 2023 – Covis Pharma Group (“Covis”), today...
